FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:973-974 September 28, 2000 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Huntington's disease is an inherited, progressive, mentally and physically disabling disorder characterized by choreoathetoid movements, dementia, and occasionally psychosis.¹ Rejection of assistance by many patients makes this an especially emotionally painful condition for family members and caregivers.

A 39-year-old man and a 52-year-old woman with Huntington's disease of 8 and 13 years' duration, respectively, were hospitalized because of agitation, aggression, and delusions that had begun 2 to 3 years earlier. In the year before admission, their uncontrollable movements had become so severe that they could not walk or assist in their own care. Both had received haloperidol . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bhidayasiri, R, Truong, D D (2004). Chorea and related disorders. Postgrad. Med. J. 80: 527-534 [Abstract] [Full Text]  
• Bonelli, R. M., Mayr, B. M., Niederwieser, G., Reisecker, F., Kapfhammer, H.-P. (2003). Ziprasidone in Huntington's Disease: The First Case Reports. J Psychopharmacol 17: 459-460 [Abstract]  
• Bonelli, R. M (2003). Olanzapine-associated seizure. The Annals of Pharmacotherapy 37: 149-150 [Full Text]